Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Overall survival of patients after BK-UM administration

From: BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

Patient no. Conventional chemotherapy after BK-UM Overall survival (months)
1 CDDP + CPT-11 (6 courses) 28.1
2 3.4
3 CDDP + CPT-11 (6 courses) 24.3
4 CDDP + CPT-11 (6 courses) 15.1
5 5.5
6 5.0
7 CDDP + CPT-11 (2 courses) 7.4
8 CDDP + IFM (2 courses) 4.2
9 3.6
10 CPT-11 (6 courses) 14.0
11 CBDCA + Doxil (6 courses) >60a
  1. CDDP cisplatin, CPT-11 irinotecan, IFM Ifosfamide, CBDCA carboplatin, Doxil doxorubicin hydrochloride liposome injection
  2. aPatient alive at 11/1/2016